ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 164 filers reported holding ACCELERON PHARMA INC in Q4 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $372,539,000 | +18.7% | 2,164,663 | -13.4% | 1.74% | +35.8% |
Q2 2021 | $313,725,000 | -11.0% | 2,500,000 | -3.8% | 1.28% | -26.9% |
Q1 2021 | $352,586,000 | +6.0% | 2,600,000 | 0.0% | 1.75% | -12.4% |
Q4 2020 | $332,644,000 | +13.7% | 2,600,000 | 0.0% | 2.00% | -1.1% |
Q3 2020 | $292,578,000 | +46.2% | 2,600,000 | +23.8% | 2.02% | +26.4% |
Q2 2020 | $200,067,000 | +2.4% | 2,100,000 | -3.4% | 1.60% | -4.6% |
Q1 2020 | $195,467,000 | +84.3% | 2,175,000 | +8.8% | 1.68% | +134.4% |
Q4 2019 | $106,040,000 | +11.8% | 2,000,000 | -16.7% | 0.72% | 0.0% |
Q3 2019 | $94,824,000 | -2.8% | 2,400,000 | +1.1% | 0.72% | +12.8% |
Q2 2019 | $97,565,000 | -11.8% | 2,375,000 | 0.0% | 0.64% | -23.7% |
Q1 2019 | $110,604,000 | +20.9% | 2,375,000 | +13.1% | 0.83% | +24.0% |
Q4 2018 | $91,455,000 | -13.2% | 2,100,000 | +14.1% | 0.67% | +7.9% |
Q3 2018 | $105,345,000 | +55.0% | 1,840,732 | +31.4% | 0.62% | +48.1% |
Q2 2018 | $67,977,000 | +24.1% | 1,401,000 | 0.0% | 0.42% | +10.8% |
Q1 2018 | $54,779,000 | +18.6% | 1,401,000 | +28.8% | 0.38% | +1.1% |
Q4 2017 | $46,175,000 | +28.5% | 1,088,000 | +13.0% | 0.38% | +17.6% |
Q3 2017 | $35,939,000 | – | 963,000 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |